Jeff Yass’s Liminatus Pharma Warrants LIMNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12K Buy
20,151
+2,589
+15% +$142 ﹤0.01% 13351
2026
Q2
$1.32K Buy
+17,562
New +$1.21K ﹤0.01% 13236
2026
Q1
– Sell
-23,906
Closed -$837 – 14469
2025
Q4
$837 Buy
+23,906
New +$2.41K ﹤0.01% 12153

Other funds holding LIMNW

Jeff Yass's LIMNW Position: Q3 2026 in Review

Jeff Yass increased its Liminatus Pharma Warrants (LIMNW) stake by 15% in Q3 2026, buying an estimated $142 and bringing the position to 20,151 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #13351.

Jeff Yass first reported a position in LIMNW in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.32K in Q2 2026. 24 funds tracked by Wall St. Rank hold LIMNW as of Q3 2026.

  • Jeff Yass held 20,151 shares of Liminatus Pharma Warrants worth $1.12K as of Q3 2026.
  • Jeff Yass bought 2,589 Liminatus Pharma Warrants shares in Q3 2026, an estimated $142.
  • Liminatus Pharma Warrants made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13351 holding.
  • Jeff Yass first reported a position in Liminatus Pharma Warrants in Q4 2025 and has held it in 3 quarters since.
  • Jeff Yass's Liminatus Pharma Warrants position peaked at $1.32K in Q2 2026.
  • 24 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.